Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models

scientific article published in August 2001

Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000047133
P698PubMed publication ID11509814

P2093author name stringG Putet
M J Boutroy
G Aulagner
R W Jelliffe
N Bleyzac
P Maire
J M Labaune
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectpharmacokineticsQ323936
amikacinQ408529
P304page(s)142-147
P577publication date2001-08-01
P1433published inNeonatologyQ2817272
P1476titleOnce-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models
P478volume80

Reverse relations

cites work (P2860)
Q52744431Amikacin: Uses, Resistance, and Prospects for Inhibition.
Q53825175Clinical Pharmacokinetics of Amikacin in Pediatric Patients: A Comprehensive Review of Population Pharmacokinetic Analyses.
Q36322918Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children
Q38657914Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonates
Q43526259Group B streptococcus and high level resistance to aminoglycosides: therapeutic implications for neonates
Q48509625Identification of a small molecule inhibitor of the aminoglycoside 6'-N-acetyltransferase type ib [AAC(6')-ib] using mixture-based combinatorial libraries
Q53730038Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance by zinc complexed with clioquinol, an ionophore active against tumors and neurodegenerative diseases.
Q35960865Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance in Klebsiella pneumoniae by zinc and copper pyrithione
Q38696468Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates
Q36850490Rise and dissemination of aminoglycoside resistance: the aac(6')-Ib paradigm
Q41516160Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey

Search more.